Allergy is a hyper-sensitivity to a specific substance which, if inhaled, ingested, touched or injected, causes characteristic symptoms.
ALL INMUNOTEK NEWS
The clinical results obtained with the new mannan-conjugated allergoids for immunotherapy against birch pollen allergy have been presented in Hamburg (Germany) ... More info
INMUNOTEK has participated in the commercial exhibition of the annual EAACI congress that has taken place in Hamburg (Germany). Although the hybrid character of... More info
The results obtained with MV140 in North American patients with recurrent uncomplicated urinary tract infections were presented at the annual meeting of the Ame... More info
INNOVATING AND SHARING IDEAS
From the outset, in 1992, our goal has been to offer innovative and competitive products of the highest quality, useful for professionals and safe and effective for the treatment of patients. To this end we have put together a highly professional and motivated team; we have outstanding facilities and a broad product porfolio.
Inmunotek products are approved by the Spanish Drug Agency and several international regulatory agencies and marketed in more than 50 countries all over the world.